Companies / DarioHealth Corp.

DarioHealth Corp.

Nasdaq: DRIOCIK 1533998NEW YORK, NY

Financials · FY2018

Revenue$7.39M
Net income$-41.71M
Total debt$39.65M
Cash$6.63M
Diluted EPS$10.12
Shares outstanding9.8M

Ownership

9.8M shares outstanding · as of Aug 11, 2026
7.8%Institutions
Ownership
Institutions7.83%766,960
Public float92.17%9,032,521

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 1

View all →
Insider% of sharesShares
Palumbo John RDirector
——

Institutional holders 17

View all →
HolderValue% of shares
Nantahala Capital Management, LLC$6.41M5.75%
Vanguard Group Inc$1.13M1.01%
Geode Capital Management, LLC$496.5K0.63%
BlackRock, Inc.$249.5K0.39%
Kestra Advisory Services, LLC$35.3K0.03%
Tower Research Capital LLC (TRC)$4.7K<0.01%
Royal Bank of Canada$3.0K<0.01%
Trust Co of Toledo NA /Oh$2.8K<0.01%
UBS Group AG$2.8K<0.01%
SBI Securities Co., Ltd.$808<0.01%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
No activity matches these filters.

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Nantahala Capital Management, LLCPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
DRIOCommon StockEquity23725P308BBG003V5P7K2